04 February 2025
Coulter Partners places Chief Business Officer at Our Future Health
Coulter Partners successfully completed a search assignment for Our Future Health and is pleased to announce the placement of Andrew Miles, as Chief Business Officer (CBO).
Our Future Health is an ambitious collaboration between the public, charity and private sectors to build the UK’s largest ever health research program – bringing people together to develop new ways to prevent, detect and treat disease such as dementia, cancer, diabetes, heart disease, asthma and stroke. The organization is supported by UK Research and Innovation, life sciences companies and disease-related charities. Ground-breaking in its scale and ambition, Our Future Health is recruiting five million volunteers to take part, from all backgrounds and from every nation across the UK. Since the program was launched in Autumn 2022, over two million volunteers have signed up to take part.
Andrew Miles is a seasoned executive with over 25 years of leadership experience in life sciences and technology sectors. Having held senior roles at Pfizer, Merck, GSK and Google, he has driven strategic growth, innovation and impactful collaborations worldwide. Previously, he spearheaded Google Cloud’s Healthcare and Life Sciences vertical for EMEA, transforming it into the company’s fastest-growing industry. He serves on the board of the Whitehall Industry Group, promoting cross-sector collaboration for societal betterment.
“We are very happy to have Andrew on board as an integral member of our leadership team. His skill set, deep and diverse experience as well as his passion and commitment align with our mission and core values.” said Dr Raghib Ali, Chief Executive and Chief Medical Officer of Our Future Health.
Dr Ali continued: "Coulter Partners' dedication to understanding our specific needs, coupled with their extensive network in the healthcare, technology and innovation space, and relentless pursuit of top talent, made this search process seamless and effective. We are grateful for their collaborative approach and commitment to delivering exceptional results."
Andrew Miles, Chief Business Officer, commented: “Despite significant advancements in medicine, many people in the UK are still spending their later life in poor health. I believe we can shift to a world where early screening opportunities are available for everyone. This will have a massive impact on the health, happiness and productivity of our society. Our Future Health can play a vital role in helping develop more effective approaches to the earlier detection and prevention of disease. I’m delighted to be part of Our Future Health and am looking forward to working with an exceptional group of scientists, clinicians and business leaders to harness the power of Our Future Health’s data and insights to help people live longer, healthier lives.”
----
Andrew Miles, Chief Business Officer, Our Future Health
About Our Future Health
For more information, please visit https://ourfuturehealth.org.uk/
About Coulter Partners
www.coulterpartners.com
Related
-
Placement News
Top hires for VC & PE portfolio companies Q3-2024
14 October 2024
-
Placement News
Top hires for VC & PE portfolio companies Q1-2024
09 April 2024
-
Placement News
Top hires for VC & PE portfolio companies Q4-2023
18 January 2024
-
Press Releases
Coulter Partners places former Evotec executives as Chief R&D Officer and SVP Biology, Discovery Strategy group at Dalriada
06 July 2023